Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer

NCT ID: NCT02129218

Last Updated: 2018-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-16

Study Completion Date

2018-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot clinical trial studies the feasibility of a low glycemic load diet in patients with stage I-III colon cancer. A low glycemic load diet includes foods that have low scores on the glycemic index. The glycemic index is a scale that measures how much a certain carbohydrate causes a person's blood sugar to rise. A low glycemic load diet may help decrease the chance of cancer coming back and improve the survival in patients with colon cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To determine the feasibility of following a low or medium glycemic load diet in patients with stage I-III (local-regional) colon cancer.

SECONDARY OBJECTIVES:

I. To determine patient-reported acceptability of diet. II. To determine nutritionist resources utilized. III. To evaluate the effect of lowering dietary glycemic load on body mass index (BMI), lipid metabolism and pro-oncogenic intermediaries of cellular metabolism.

OUTLINE: Patients are sequentially enrolled in 1 of 4 possible cohorts as needed based on the feasibility of the prior cohort.

COHORT 1: Patients follow a low glycemic load diet with standard dietary intervention (contact with nutritionist in person every 2 weeks with phone contact on the alternating weeks) for 12 weeks.

COHORT 2: Patients follow a low glycemic load diet with intensified dietary intervention (contact with nutritionist in person every week) for 12 weeks.

COHORT 3: Patients follow a medium glycemic load diet with standard dietary intervention for 12 weeks.

COHORT 4: Patients follow a medium glycemic load diet with intensified dietary intervention for 12 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stage I Colon Cancer Stage II Colon Cancer Stage III Colon Cancer Stage I Rectal Cancer Stage II Rectal Cancer Stage III Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort 1: Low glycemic load with standard diet

Patients follow a low glycemic load diet with a standard dietary intervention for 12 weeks.

Group Type EXPERIMENTAL

questionnaire administration

Intervention Type OTHER

Ancillary studies including three day food record, twenty-four hour dietary recall, and a food acceptability questionnaire.

Standard Dietary Intervention

Intervention Type BEHAVIORAL

Participants will be contacted by a nutritionist, in person every 2 weeks with phone contact on the alternating weeks. At the initial visit, each participant will be given verbal and written patient education materials, including low glycemic load diet recipes, meal plans, food preparation, and grocery shopping information. Individual instruction will be tailored to their baseline dietary preferences (e.g. vegan, allergies, etc).

Low glycemic load

Intervention Type BEHAVIORAL

Cohort 2: Low glycemic load with intensified diet

Patients follow a low glycemic load diet with intensified dietary intervention for 12 weeks.

Group Type EXPERIMENTAL

questionnaire administration

Intervention Type OTHER

Ancillary studies including three day food record, twenty-four hour dietary recall, and a food acceptability questionnaire.

laboratory biomarker analysis

Intervention Type OTHER

Correlative studies

Intensified Dietary Intervention

Intervention Type BEHAVIORAL

Patients will be contacted weekly, in person, by a nutritionist . Participants will take part in a cooking demonstration at the time of their initial visit. The demonstration will be hands-on and participants will be able to sample foods and recipes. In addition to grocery shopping information, participants will be accompanied by a nutritionist to their local grocery store to practice new shopping habits for their target dietary glycemic load. Each participant will also receive weekly random phone calls to assess his or her progress.

Low glycemic load

Intervention Type BEHAVIORAL

Cohort 3: Medium glycemic load with standard diet

Patients follow a medium glycemic load diet with standard dietary intervention for 12 weeks.

Group Type ACTIVE_COMPARATOR

questionnaire administration

Intervention Type OTHER

Ancillary studies including three day food record, twenty-four hour dietary recall, and a food acceptability questionnaire.

laboratory biomarker analysis

Intervention Type OTHER

Correlative studies

Standard Dietary Intervention

Intervention Type BEHAVIORAL

Participants will be contacted by a nutritionist, in person every 2 weeks with phone contact on the alternating weeks. At the initial visit, each participant will be given verbal and written patient education materials, including low glycemic load diet recipes, meal plans, food preparation, and grocery shopping information. Individual instruction will be tailored to their baseline dietary preferences (e.g. vegan, allergies, etc).

Medium Glycemic Load

Intervention Type BEHAVIORAL

Cohort 4: Medium glycemic load with intensified diet

Patients follow a medium glycemic load diet with intensified dietary intervention for 12 weeks.

Group Type ACTIVE_COMPARATOR

questionnaire administration

Intervention Type OTHER

Ancillary studies including three day food record, twenty-four hour dietary recall, and a food acceptability questionnaire.

laboratory biomarker analysis

Intervention Type OTHER

Correlative studies

Intensified Dietary Intervention

Intervention Type BEHAVIORAL

Patients will be contacted weekly, in person, by a nutritionist . Participants will take part in a cooking demonstration at the time of their initial visit. The demonstration will be hands-on and participants will be able to sample foods and recipes. In addition to grocery shopping information, participants will be accompanied by a nutritionist to their local grocery store to practice new shopping habits for their target dietary glycemic load. Each participant will also receive weekly random phone calls to assess his or her progress.

Medium Glycemic Load

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire administration

Ancillary studies including three day food record, twenty-four hour dietary recall, and a food acceptability questionnaire.

Intervention Type OTHER

laboratory biomarker analysis

Correlative studies

Intervention Type OTHER

Standard Dietary Intervention

Participants will be contacted by a nutritionist, in person every 2 weeks with phone contact on the alternating weeks. At the initial visit, each participant will be given verbal and written patient education materials, including low glycemic load diet recipes, meal plans, food preparation, and grocery shopping information. Individual instruction will be tailored to their baseline dietary preferences (e.g. vegan, allergies, etc).

Intervention Type BEHAVIORAL

Intensified Dietary Intervention

Patients will be contacted weekly, in person, by a nutritionist . Participants will take part in a cooking demonstration at the time of their initial visit. The demonstration will be hands-on and participants will be able to sample foods and recipes. In addition to grocery shopping information, participants will be accompanied by a nutritionist to their local grocery store to practice new shopping habits for their target dietary glycemic load. Each participant will also receive weekly random phone calls to assess his or her progress.

Intervention Type BEHAVIORAL

Low glycemic load

Intervention Type BEHAVIORAL

Medium Glycemic Load

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients must have stage I-III colon or rectal cancer and have undergone definitive therapy; definitive therapy may have included surgery alone, or surgery plus neoadjuvant and/or adjuvant therapy
* Patients must regularly consume a diet with a glycemic load \> 150 as estimated through the 3 day food recall
* Patients must readily be available for a 3 month period and agree to participate in regular dietary adherence assessments (surveys and phone interviews)

Exclusion Criteria

* Current participation in an intervention targeting diet or exercise
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Case Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michelle Treasure, MD

Role: STUDY_DIRECTOR

Case Comprehensive Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Case Comprehensive Cancer Center

Cleveland, Ohio, United States

Site Status

Metrohealth Medical Center

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2014-00831

Identifier Type: REGISTRY

Identifier Source: secondary_id

CASE7213

Identifier Type: OTHER

Identifier Source: secondary_id

P30CA043703

Identifier Type: NIH

Identifier Source: secondary_id

View Link

CASE7213

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ketogenic Diet in Advanced Cancer
NCT01716468 COMPLETED NA